Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Diagnostic Eye Drops on Tear Film Thickness
NCT07230548Phase 3Completed
- Sponsor
- Medical University of Vienna
- Start
- Jun 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxybuprocaine, fluorescein, sponsored by Medical University of Vienna. Started Jun 2020; status: completed.
02
Drugs
oxybuprocainefluorescein
Beyond the preview
Go deeper on NCT07230548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07230548.